Hepworth E, Movahedi M, Rampakakis E, Mirza R, Lau A, Cesta A, Pope J, Sampalis JS, Bombardier C. Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database. Curr Rheumatol Rev. 2021;17(3):349-359. doi: 10.2174/1573397116666201211130337. PMID: 33308132.
Ahluwalia V, Rampakakis E, Movahedi M, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: Results from the Ontario Best Practices Initiative. Clinical Rheumatology. November 2017, Volume 36, Issue 11, pp 241-2430. DOI: 10.1007/s10067-017-3805-4. Epub 2017 Sep 6. PMID: 28879413.
Ruban TN, Jacob B, Pope JE, Keystone EC, Bombardier C, Kuriya B. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative. Clin Rheumatol. 2016 Mar;35(3):759-63. doi: 10.1007/s10067-015-3031-x. Epub 2015 Aug 6. PMID: 26245721.